Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis Starts To Climb Out Of Manufacturing Hole
Pharmalot
Monday, November 12, 2012 - 10:55am
tags:
drug manufacturing, Novartis
UK Glaxo Employee Blows Whistle On Drug Promotions
Pharmalot
Monday, November 12, 2012 - 10:53am
tags:
UK, GSK, whistleblower lawsuits, Revolade, off-label
Pfizer: Overvalued At Current Price Levels
Seeking Alpha
Monday, November 12, 2012 - 10:50am
tags:
Pfizer
Survey Of The Pancreatic Cancer Drug Market With Celgene's Abraxane In Focus
Seeking Alpha
Sunday, November 11, 2012 - 9:56am
tags:
pancreatic cancer, Celgene, Abraxane
Biotech Weekend Recap: Important Developments And Big Releases
Seeking Alpha
Sunday, November 11, 2012 - 9:49am
tags:
Amarin, Vivus, Dendreon, Arena Pharmaceuticals, Pharmacyclics, Biomarin
Jazz Pharma Earnings: A Mixed Picture
Wall St Cheat Street
Sunday, November 11, 2012 - 9:47am
tags:
Jazz Pharmaceuticals
Mylan Announces Ortho Tri-Cyclen LO® Settlement Agreement
Melodika
Sunday, November 11, 2012 - 9:45am
tags:
Mylan, Ortho Tri-cyclen, lawsuits, generics
Horizon Pharma Presents Clinical Data Demonstrating RAYOS(R) (prednisone) Delayed-Release Tablets Reduce Fatigue in Patients With Active Rheumatoid Arthritis
Yahoo/MarketWire
Sunday, November 11, 2012 - 9:34am
tags:
Horizon Therapeutics, Rayos, rheumatoid arthritis
Is This Pharma Stock Worth Buying Now?
Motley Fool
Sunday, November 11, 2012 - 9:32am
tags:
Perrigo
Amarin Still Playing the Dating Game
Motley Fool
Sunday, November 11, 2012 - 9:31am
tags:
Amarin, Vascepa
Pfizer Loses Its Cash Cow!
Motley Fool
Sunday, November 11, 2012 - 9:28am
tags:
Pfizer, Lipitor
Is It Pfizer Now That's Dodging Tax In The UK?
Forbes
Sunday, November 11, 2012 - 9:25am
tags:
Pfizer
Abbott Presents Promising Phase 2b Interferon-free Hepatitis C Results at 2012 Liver Meeting®
Yahoo/PR NewsWire
Sunday, November 11, 2012 - 9:24am
tags:
Abbott Laboratories, hepatitis C
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sunday, November 11, 2012 - 9:21am
tags:
Vivus, Orexigen, OraSure
This Week in Biotech: Part 2
Motley Fool
Sunday, November 11, 2012 - 9:19am
tags:
Biocryst, Catalyst Pharmaceutical Partners, Pluristem Therapeutics, Vivus, Arena Pharmaceuticals, Eisai
This Week in Biotech: Part 1
Motley Fool
Sunday, November 11, 2012 - 9:17am
tags:
Novartis, Novo Nordisk, Corcept Therapeutics, Biomarin, Sequenom
Supreme Court (in Canada) paves way for generic Viagra, ends monopoly
Canada.com, Canada
Saturday, November 10, 2012 - 8:40am
tags:
Viagra, Pfizer
Teva Pharmaceutical - A Fundamentals-Driven Dividend Growth Stock Value Idea For November 5
Seeking Alpha
Saturday, November 10, 2012 - 8:37am
tags:
Teva Pharmaceuticals
Will This Big Pharma Continue to Trade Up?
Motley Fool
Saturday, November 10, 2012 - 8:32am
tags:
Eli Lilly
Does VIVUS Need a Partner?
Motley Fool
Saturday, November 10, 2012 - 8:27am
tags:
Vivus, Qsymia, weight loss, obesity

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.